New 20-cent trade receives $122 Million from Gov’t + FDA “Breakthrough” status +...

[Header] Dear Reader, It’s part special situation… part “asymmetric” trade… My colleague John Pangere recently told me about a new AI/healthcare company. The U.S. government has already granted it $122 million in funding… It has received FDA “Breakthrough Designation Status.” That’s similar to fast-tracking a drug… [And right now you can invest in it for less than 22 cents a share!]( So with an investment of just $50, you can control 250 shares… With $500, you can control 2,500 shares… The insiders on Washington and Wall Street could NEVER get in on a deal this tiny. But as part of my urgent private briefing, available for the next two days only, you can get all the details. [Click here to watch the replay and catch up now on Wall Street and Washington’s Unfair AI Investment Advantage Exposed.]( Sincerely, [Nomi Prins signature] Nomi Prins Editor, Rogue Economics © 2023 Rogue Economics. All rights reserved. 455 NE 5th Ave Suite D384, Delray Beach, FL 33483. To ensure our emails continue reaching your inbox, please [add our email address]( to your address book. No longer wish to receive special offers from us? Click [here]( for options.